Nathaniel Wang is the founder of Replicate Bioscience. Replicate Bioscience has raised $40M in total funding. Latest round: Series A. Backed by ATP.
Nathaniel Wang, Ph.D., is the Chief Executive Officer of Replicate Bioscience, a company pioneering self-replicating RNA (srRNA) therapeutics. Replicate Bioscience raised $40 million in Series A funding from ATP to advance its srRNA programs. Dr. Wang previously collaborated on srRNA technologies at Synthetic Genomics and Novartis Vaccines and Diagnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library